DETQ is an experimental drug which acts as a positive allosteric modulator of the dopamine D1 receptor. It increases the D1 receptor-mediated response to endogenous dopamine levels, and was developed as a potential treatment for Parkinson's disease.
DETQ is an experimental drug which acts as a positive allosteric modulator of the dopamine D1 receptor. It increases the D1 receptor-mediated response to endogenous dopamine levels, and was developed as a potential treatment for Parkinson's disease.
Source: Wikipedia "DETQ" · CC BY-SA 4.0
Share this article: X · Bluesky